Trademark on Trilexon

Greyson International, Inc. Receives Notice of Allowance for Trademark on Trilexon™

Delray Beach, FL – August 27, 2008 — GREYSON INTERNATIONAL, INC (GYSN.PK) announced today that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for Trilexon™, a state-of-the-art delivery system designed to improve effectiveness of skin-care, hair-care and other topical applications.

“We highly anticipate the introduction of Trilexon™ as a new delivery method to improve effectiveness of virtually every topical application on a worldwide level,” said Greyson President and CEO Harvey Tauman.

Greyson International intends to enter the royalty division of business and effectively license Trilexon™ to clients in the drug, cosmetic and toiletry industries, upon which Greyson will retain a percentage of sales from products utilizing the Trilexon™ delivery system.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products including six skin care products in the Greyson line, as well as the Trilexon™ system, a new delivery method which will improve effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. For more information, visit www.jennifergreyson.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.